Shuji Yamamoto

Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity

Shuji Yamamoto, Toshiko Yamamoto, Tateshi Kataoka et al. · The Journal of Immunology · 1992 · 474 citations

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness

Shuji Yamamoto, Kimberly C. Sippel, Eliot L. Berson et al. · Nature Genetics · 1997 · 279 citations

Ocular Disease, Molecular Physiology, Molecular Neuroscience +12

Ocular Surface Abnormalities in Aniridia

Kohji Nishida, Shigeru Kinoshita, Yuichi Ohashi et al. · American Journal of Ophthalmology · 1995 · 207 citations

Ocular Disease, Experimental Ophthalmology, Ophthalmology +4

Injection Volume and Anesthetic Effect in Serratus Plane Block

Tatsuya Kunigo, Takeshi Murouchi, Shuji Yamamoto et al. · Regional Anesthesia & Pain Medicine · 2017 · 150 citations